175 related articles for article (PubMed ID: 20493593)
21. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
Yan X; Lv Z; Wen J; Zhao S; Xu Z
Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
[TBL] [Abstract][Full Text] [Related]
22. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.
Wang JX; Zhang YB; Liu ML; Wang B; Chai Y; Li SJ; Guo HY
Eur J Med Chem; 2011 Jun; 46(6):2421-6. PubMed ID: 21481984
[TBL] [Abstract][Full Text] [Related]
24. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
Sriram D; Aubry A; Yogeeswari P; Fisher LM
Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
26. Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains.
Rijo P; Simões MF; Francisco AP; Rojas R; Gilman RH; Vaisberg AJ; Rodríguez B; Moiteiro C
Chem Biodivers; 2010 Apr; 7(4):922-32. PubMed ID: 20397225
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.
Lv K; Sun Y; Sun L; Wei Z; Guo H; Wu J; Liu M
ChemMedChem; 2012 Jul; 7(7):1230-6. PubMed ID: 22639240
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids.
Senthilkumar P; Dinakaran M; Banerjee D; Devakaram RV; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(5):2558-69. PubMed ID: 18078756
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3,5-difluoropyridin-2-yl)fluoroquinolone derivatives containing an oxime functional moiety.
Huang J; Wang M; Wang B; Wu Z; Liu M; Feng L; Zhang J; Li X; Yang Y; Lu Y
Bioorg Med Chem Lett; 2016 May; 26(9):2262-7. PubMed ID: 27020299
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
Xu Z; Zhang S; Song X; Qiang M; Lv Z
Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
[TBL] [Abstract][Full Text] [Related]
32. 5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures.
Sriram D; Yogeeswari P; Vyas DR; Senthilkumar P; Bhat P; Srividya M
Bioorg Med Chem Lett; 2010 Aug; 20(15):4313-6. PubMed ID: 20615698
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl alpha-(5-aryl-1, 3, 4-thiadiazole-2-ylthio)acetates.
Foroumadi A; Soltani F; Moallemzadeh-Haghighi H; Shafiee A
Arch Pharm (Weinheim); 2005 Mar; 338(2-3):112-6. PubMed ID: 15756694
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis and In Vitro Anti-microbial Evaluation of Ethylene/ Propylene-1H-1,2,3-Triazole-4-Methylene-tethered Isatin-coumarin Hybrids.
Jin X; Xu Y; Yang X; Chen X; Wu M; Guan J; Feng L
Curr Top Med Chem; 2017; 17(29):3213-3218. PubMed ID: 29243578
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacterial agents.
Azéma J; Guidetti B; Korolyov A; Kiss R; Roques C; Constant P; Daffé M; Malet-Martino M
Eur J Med Chem; 2011 Dec; 46(12):6025-38. PubMed ID: 22036229
[TBL] [Abstract][Full Text] [Related]
36. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives.
Sriram D; Bal TR; Yogeeswari P; Radha DR; Nagaraja V
J Gen Appl Microbiol; 2006 Aug; 52(4):195-200. PubMed ID: 17116967
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents.
Eswaran S; Adhikari AV; Pal NK; Chowdhury IH
Bioorg Med Chem Lett; 2010 Feb; 20(3):1040-4. PubMed ID: 20056418
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
[TBL] [Abstract][Full Text] [Related]
40. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
